~~<i id='A9C1A382C6'><strike id='A9C1A382C6'><tt id='A9C1A382C6'><pre id='A9C1A382C6'></pre></tt></strike></i>~~

Home» explore» hotspot

hotspot

author：entertainment 2025-10-06 11:54:36 Page View：58

ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

Arch declined to comment on the new fundraising.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Fauci’s Covid grilling leads GOP to weigh foreign research rules
Next article： Jerome Adams on the need for new antivirals for Covid

knowledge

Drug repurposing or repositioning? The language matters

AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

Caregivers of transplant patients call for more support, training

IraCoppermanwithhiswife,GlendaDaggert.JessicaRinaldi/GlobeStaffBythetimehiswifeGlendaDaggertreceived

After affirmative action ruling, medical educators look to 'holistic review'

AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

Friends ask where James Watson's attitudes about race came from

JamesWatsonDanielMordzinski/AFP-GettyEvenbeforeadocumentaryonbiologistJamesWatsonairedonWednesdaynig